The Alzheimer's disease assessment scale: Patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials

Neurology

Volumn 48, Issue 6, 1997, Pages 1511-1517

  Doraiswamy, P M ^a   Bieber, F ^b   Kaiser, L ^b   Krishnan, K R ^a   Reuning Scherer, J ^c   Gulanski, B ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BAYER CORPORATION   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; TACRINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENTAL TEST; MULTICENTER STUDY; ONSET AGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM;

EID: 0030837745     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1511     Document Type: Article

References (18)

1. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
2. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994;151:390-396.
3. Davis KL, Thai LJ, Gamzu ER, et al. A double-blind multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992;327:1253-1259.
4. Zee RF, Landreth ES, Vicari SK, et al. Alzheimer Disease Assessment Scale: useful for both early detection and staging of dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 1992;6,2:89-102.
5. Zee RF, Landreth ES, Vicari SK, et al. Alzheimer's Disease Assessment Scale: a subtest analysis. Alzheimer Dis Assoc Disord 1992;6,3:164-181.
6. Mortimer J, Graves A. Education and socio-economic determinants of dementia and Alzheimer's disease. Neurology 1993; 43:s39-s44.
7. Cram R, Anthony J, Bassett S, Folstein M. Population-based norms for the mini-mental state examination by age and educational level. JAMA 1993;269:2386-2391.
8. Doraiswamy PM, Krishen A, Stallone F, et al. Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of education. Neurology 1995;45:1980-1984.
9. Doraiswamy PM, Krishen A, Stallone F, et al. NSAID use and cognition in Alzheimer's disease. Neurology (in press).
10. Rich JB, Rasmusson DX, Folstein MF, et al. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995;45:51-55.
11. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140: 256-261.
12. Buckwalter JG, Sobel E, Dunn ME, Diz MM, Henderson VW. Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neurol 1993;50:757-760.
13. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's disease. Part V. A Normative study of the neuropsychological battery. Neurology 1994;44:609-614.
14. Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW. Gender differences in language of AD patients: a longitudinal study. Neurology 1995;45:299-302.
15. Reisberg B, Ferris S, De Leon MJ, et al. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
16. Schwartz GE. Development and validation of the GERRI. Psychol Rep 1983;53:479-488.
17. Diagnostic and statistical manual of mental disorders, 3rd ed., revised. Washington, DC: American Psychiatric Association, 1987.
18. Huff FJ, Growdon JH, Corkin S, et al. Age at onset and rate of progression of Alzheimer's disease. J Am Geriatr Soc 1987;35: 27-30.